Canada’s Drug Agency | Drugs, Health Technologies and Systems.
Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Breath Tests for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Details

Files
Project Status:
Completed
Project Line:
Horizon Scan
Project Sub Line:
Health Technology Update
Project Number:
EN0039-000

This Horizon Scan report examines the use of breath tests to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 infections. Breath tests for SARS-CoV-2 work by analyzing the volatile organic compounds (compounds produced by virus-infected cells) present in exhaled breath. Issues related to these tests, such as current practice and cost, are explored in this report.

Files

Breath Tests for the Detection of Severe Acute Respiratory Syndrome Coronavirus… View PDF
Last Updated : August 6, 2021